share_log

賽生藥業：截至2024年1月31日之股份發行人的證券變動月報表

SCICLONE PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024

香港交易所 ·  Feb 6 07:47
Summary by Moomoo AI
賽生藥業於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在1,000,000,000美元，面值為0.00005美元，總額為50,000美元，本月無增減。此外，賽生藥業的股份期權計劃中，購股權激勵計劃於本月內有60,000股份被行使，而首次公開發售後購股權計劃則有135,500股份被行使。本月內因行使期權所得資金總額為1,187,042港元。公司確認，所有發行的證券均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
賽生藥業於2024年2月6日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在1,000,000,000美元，面值為0.00005美元，總額為50,000美元，本月無增減。此外，賽生藥業的股份期權計劃中，購股權激勵計劃於本月內有60,000股份被行使，而首次公開發售後購股權計劃則有135,500股份被行使。本月內因行使期權所得資金總額為1,187,042港元。公司確認，所有發行的證券均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Sai Sang Pharmaceuticals filed with Hong Kong Trading and Clearing Limited on 6 February 2024 its Monthly Securities Change Report for the year ended 31 January 2024. The report showed that the company's regulated/registered capital deposit remained at $1,000,000,000 with a face value of $0.00005 for a total of $50,000, with no increase this month. In addition, 60,000 shares were exercised in the share option program of Caiseng Pharmaceuticals during the month, and 135,500 shares were exercised in the share option plan following the initial public offering. The total amount of capital gained from the exercise of options during the month was HK$1,187,042. The Company confirms that all securities issued have been authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Sai Sang Pharmaceuticals filed with Hong Kong Trading and Clearing Limited on 6 February 2024 its Monthly Securities Change Report for the year ended 31 January 2024. The report showed that the company's regulated/registered capital deposit remained at $1,000,000,000 with a face value of $0.00005 for a total of $50,000, with no increase this month. In addition, 60,000 shares were exercised in the share option program of Caiseng Pharmaceuticals during the month, and 135,500 shares were exercised in the share option plan following the initial public offering. The total amount of capital gained from the exercise of options during the month was HK$1,187,042. The Company confirms that all securities issued have been authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more